RxDoctor Payments Data

Coy Peters, DO

Family Medicine · Broken Arrow, OKNPI 1164841557

Payments from drug & device makers

$9,575in general payments, 2019–2025

Across 647 payments — averaging $14.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • GSK$1K
  • Pfizer$1K
  • Novo Nordisk$986
  • Lilly USA, LLC$882
  • AstraZeneca$430
  • plus $4K from 35 others

What the payments were for

  • Food & beverage$9,566100%
  • Education$90%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$9,575 in reported general payments places this provider in the 90th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma

Medicare billing

Part B allowed, 2024
$61,854
Medicare patients
294
Services billed
1,141

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban76$85,138
OzempicSemaglutide36$54,413
JardianceEmpagliflozin40$47,888
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$47,879
XareltoRivaroxaban36$39,026
Humulin R U-500 KwikpenInsulin Regular, Human13$27,945
JanuviaSitagliptin Phosphate26$27,731
Tresiba Flextouch U-200Insulin Degludec16$26,553
Repatha SureclickEvolocumab31$25,772
TrulicityDulaglutide13$23,763
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr39$23,003
FarxigaDapagliflozin Propanediol14$19,385
LinzessLinaclotide19$19,318
Synjardy XrEmpagliflozin/Metformin Hcl15$18,782
RybelsusSemaglutide11$18,307

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$1,004$85,13876 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$1,099$79,319101 claims
Boehringer IngelheimJardiance, Synjardy Xr, Stiolto Respimat$222$74,99168 claims
Novo NordiskOzempic, Rybelsus$986$72,71947 claims
Johnson & JohnsonXarelto$362$39,02636 claims
Lilly USA, LLCTrulicity, Mounjaro$882$38,06927 claims
MerckJanuvia, Belsomra$309$34,46542 claims
AstraZenecaFarxiga$430$19,38514 claims
AbbVieLinzess$1,316$19,31819 claims
Astellas Pharma US IncMyrbetriq$168$8,67414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,730 family medicine providers in Oklahoma.

Other family medicine in Broken Arrow

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →